INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 41 filers reported holding INTEC PHARMA LTD JERUSALEM in Q1 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $318,000 | -12.6% | 42,236 | -34.4% | 0.39% | +14.9% |
| Q3 2018 | $364,000 | +27.7% | 64,396 | -0.6% | 0.34% | +232.7% |
| Q2 2018 | $285,000 | -27.8% | 64,817 | +0.8% | 0.10% | -76.5% |
| Q1 2018 | $395,000 | +5.3% | 64,280 | -11.7% | 0.43% | -5.9% |
| Q4 2017 | $375,000 | -44.9% | 72,782 | -4.4% | 0.46% | -34.2% |
| Q3 2017 | $681,000 | – | 76,139 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MEITAV INVESTMENT HOUSE LTD | 120,991 | $418,000 | 0.02% |